EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 120 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $145 | -99.9% | 9,200 | +217.2% | 0.00% | 0.0% |
| Q2 2022 | $128,000 | -72.2% | 2,900 | -68.8% | 0.00% | -50.0% |
| Q1 2022 | $460,000 | +586.6% | 9,300 | +481.2% | 0.00% | – |
| Q3 2020 | $67,000 | -88.5% | 1,600 | -86.9% | 0.00% | -100.0% |
| Q2 2020 | $585,000 | +7.9% | 12,200 | +3.4% | 0.00% | 0.0% |
| Q1 2020 | $542,000 | -20.8% | 11,800 | +3.5% | 0.00% | 0.0% |
| Q4 2019 | $684,000 | -47.9% | 11,400 | -50.9% | 0.00% | 0.0% |
| Q3 2019 | $1,312,000 | +90.1% | 23,200 | +87.1% | 0.00% | 0.0% |
| Q2 2019 | $690,000 | +15.0% | 12,400 | +4.2% | 0.00% | 0.0% |
| Q1 2019 | $600,000 | +25.3% | 11,900 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $479,000 | -41.9% | 11,900 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $825,000 | -8.3% | 11,900 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $900,000 | +757.1% | 11,900 | +495.0% | 0.00% | – |
| Q1 2018 | $105,000 | -18.0% | 2,000 | -16.7% | 0.00% | -100.0% |
| Q4 2017 | $128,000 | -82.8% | 2,400 | -80.8% | 0.00% | -66.7% |
| Q3 2017 | $745,000 | +1.6% | 12,500 | +34.4% | 0.00% | 0.0% |
| Q2 2017 | $733,000 | +10.6% | 9,300 | +16.2% | 0.00% | 0.0% |
| Q1 2017 | $663,000 | +168.4% | 8,000 | +31.1% | 0.00% | +200.0% |
| Q1 2016 | $247,000 | -66.8% | 6,100 | -27.4% | 0.00% | -66.7% |
| Q4 2015 | $744,000 | +2.6% | 8,400 | -14.3% | 0.00% | 0.0% |
| Q3 2015 | $725,000 | -8.5% | 9,800 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $792,000 | – | 9,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |